drugset / Trial / NCT02500225

Comparison the Effects of Etomidate and Sevoflurane During Electroconvulsive Therapy

NCT02500225

Phase 4 Completed 25 enrolled Inonu University
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of the study was to investigate the effects of etomidate or sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles.

Timeline

Start
2017-01
Primary completion
2017-02
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etomidate Small molecule 0.2 mg/kg
Comparator Sevoflurane Other / unclassified 8 % Inhaled

Indications

No indication recorded.